| NCT ID | NCT05746260 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-03-01 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will explore whether sleep disruption in the sub-acute phase of stroke explains variation in clinical motor outcomes, and whether this relationship is mediated by variation in behavioural measures of overnight consolidation.
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study OR a positive opinion from a consultee is provided by a family member or carer (relative or friend) willing to provide personal consultee (PC) advice * Aged 18 years or above * Within 1 month of onset of stroke affecting the upper limb as confirmed by clinical diagnosis Exclusion Criteria: * Other neurological condition affecting movement (such as Parkinson's disease, Multiple Sclerosis)
Contact & Investigator
Heidi Johansen-Berg, Professor
PRINCIPAL INVESTIGATOR
University of Oxford
Frequently Asked Questions
Who can join the NCT05746260 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05746260 currently recruiting?
Yes, NCT05746260 is actively recruiting participants. Contact the research team at melanie.fleming@ndcn.ox.ac.uk for enrollment information.
Where is the NCT05746260 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT05746260 clinical trial?
NCT05746260 is sponsored by University of Oxford. The principal investigator is Heidi Johansen-Berg, Professor at University of Oxford. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.